I
INMB
Inmune Bio Inc
1.400
-0.030-2.10%Pre Market: 1.396 -0.004 -0.31%05:12 05/28 EDT
OPEN/PREV CLOSE1.420/1.430
TODAY RANGE1.395-1.455
VOL10
MARKET CAP37.22M
52 WEEK RANGE1.090-11.64
AVG VOL (3M)438.49K
% TURNOVER0.82%
TURNOVER0
P/E (TTM)-0.8262
% RANGE4.20%
EPS(TTM)-1.6945
P/E(FORWARD)-2.0438
P/B1.897
BVPS0.7382
DIVIDEND--
P/S736.84
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP32.99M
SHARES OUTSTANDING26.59M
NEXT EARNINGS08/05-08/10
FREE FLOAT23.57M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/20 07:12
Inmune Bio Charts Regulatory Path Amid Cash Constraints
TipRanks·05/14 14:59
INmune Bio receives fast track designation from FDA for XPro
TipRanks·05/09 00:44
Inmune Bio Advances CORDStrom Amid Funding Pressures
Seeking Alpha·05/07 21:10
INmune Bio GAAP EPS of -$0.20 beats by $0.04
Reuters·05/07 20:48
INmune Bio Q1 net loss narrows on lower R&D expenses
Reuters·05/07 20:01
INMUNE BIO Q1 EPS USD -0.2
Dow Jones·05/07 20:00
Press Release: INmune Bio Inc. Announces First -2-
Dow Jones·05/07 20:00
*INmune Bio 1Q Loss/Shr 20c >INMB
TipRanks·05/05 22:41
INmune Bio Expands Cord Tissue License for CORDStrom Platform
Same Industry
Name/Symbol
Change%
Price